Literature DB >> 3122042

Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei.

V Bellofatto1, A H Fairlamb, G B Henderson, G A Cross.   

Abstract

Procyclic Trypanosoma brucei grown in semi-defined media are sensitive to alpha-difluoromethylornithine (DFMO) (EC50 100 microM), an inhibitor of ornithine decarboxylase (ODC), a key enzyme in polyamine biosynthesis. Organisms resistant to 5 mM DFMO (EC50 greater than 20 mM) were obtained by passage in incremental amounts of drug. Resistant and wild-type cells accumulated DFMO by passive diffusion with a consequent decrease in polyamine levels, indicating inhibition of ODC in both cell types. The resistant phenotype was stable in the absence of DFMO, in which state there was no increase in ODC abundance or activity. By kinetic analysis, the ODC of resistant cells appeared normal. In wild-type and resistant cells, [3H]DFMO equally and uniquely affinity-labelled a 50 kDa polypeptide corresponding to the ODC subunit. Levels of ODC and tubulin mRNAs were elevated 4-fold in resistant cells grown in the presence of DFMO, although there was no indication of gene amplification. The intracellular concentration of dihydrotrypanothione (N1,N8-bis(glutathionyl)-spermidine), a redox intermediate unique to kinetoplastids, was unchanged in resistant cells growing in DFMO but was halved in wild-type cells exposed to DFMO for 48 h. The exceptionally elevated levels of ornithine found in DFMO-treated resistant cells most likely play a crucial role in cell survival by maintaining intracellular concentrations of dihydrotrypanothione by competing with DFMO for ODC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3122042     DOI: 10.1016/0166-6851(87)90086-7

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  16 in total

1.  Changes in gene expression in response to polyamine depletion indicates selective stabilization of mRNAs.

Authors:  I Veress; S Haghighi; A Pulkka; A Pajunen
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  In search of new lead compounds for trypanosomiasis drug design: a protein structure-based linked-fragment approach.

Authors:  C L Verlinde; G Rudenko; W G Hol
Journal:  J Comput Aided Mol Des       Date:  1992-04       Impact factor: 3.686

3.  Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.

Authors:  M Iten; H Mett; A Evans; J C Enyaru; R Brun; R Kaminsky
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Phenotypic analysis of trypanothione synthetase knockdown in the African trypanosome.

Authors:  Mark R Ariyanayagam; Sandra L Oza; Maria Lucia S Guther; Alan H Fairlamb
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

5.  Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense.

Authors:  C J Bacchi; H C Nathan; T Livingston; G Valladares; M Saric; P D Sayer; A R Njogu; A B Clarkson
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Alpha-difluoromethylornithine-resistant cell lines obtained after one-step selection of Leishmania mexicana promastigote cultures.

Authors:  C P Sánchez; J Mucci; N S González; A Ochoa; M M Zakin; I D Algranati
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

7.  Structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei determined from Laue data.

Authors:  F M Vellieux; J Hajdu; C L Verlinde; H Groendijk; R J Read; T J Greenhough; J W Campbell; K H Kalk; J A Littlechild; H C Watson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  A molecular mechanism for eflornithine resistance in African trypanosomes.

Authors:  Isabel M Vincent; Darren Creek; David G Watson; Mohammed A Kamleh; Debra J Woods; Pui Ee Wong; Richard J S Burchmore; Michael P Barrett
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

Review 9.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

10.  Cloning and expression of the hypoxanthine-guanine phosphoribosyltransferase gene from Trypanosoma brucei.

Authors:  T E Allen; B Ullman
Journal:  Nucleic Acids Res       Date:  1993-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.